Altman, Jensen Huang and Other AI Kings Stir Market Fear
Investors are jittery as AI powerhouses push for faster adoption, while critics warn of overhype. This piece breaks d...
Which Is Better Target Date Funds Or Age Based Strategy: Brief. A quick look at the trade-offs between these approaches to help you decide what suits you.
27,345 articlesInvestors are jittery as AI powerhouses push for faster adoption, while critics warn of overhype. This piece breaks d...
Investing often favors flashy stories, but some of the strongest returns come from straightforward, reliable business...
Kinsale Capital is carving a niche in the specialty insurance market. This article breaks down why it might be a stro...
Analysts warn that the AI data center boom championed by leading tech firms may deliver far less capacity than promis...
Pulmonx is navigating a pivotal year as it advances its lung care devices while contending with pacing competition an...
Can bloom energy stock going to $200 actually happen? This guide breaks down the catalysts, risks, and practical stra...
Crispr Therapeutics Stock Absurdly Cheap signals a rare biotech bargain. Learn what could drive a 437% upside, the ca...
Alta Fox quietly increases its XPEL exposure, lifting the stake to about 15.5% after a roughly $58 million purchase. ...
CoreWeave sits at the center of the AI compute boom, offering scalable GPU capacity. This article breaks down the bul...
IMDX kicked off 2026 with a solid Q1 showing, delivering revenue growth and improving margins while guiding higher fu...
Analysts map a path for UPS through 2026 and beyond, highlighting margin resilience, volume growth, and cost control ...
New market dynamics push five names into focus as AI, memory demand, and energy trends redefine winners and losers. A...